Ra mắt thuốc kháng thể chống COVID-19 có hiệu quả bảo vệ trong 6 tháng
Ngày 18/11, hãng dược phẩm AstraZeneca (Anh-Thụy Điển) cho biết thuốc kháng thể chống COVID-19 dạng tiêm mang tên Evusheld của hãng này cho hiệu quả bảo vệ lên đến 83% trong vòng 6 tháng.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu